CCL vs COLL · P/E 15, rev $25.02B vs P/E 17, rev $181.9M
Carnival Corporation (CCL) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Carnival Corporation (CCL) is a travel services company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CCL revenue for 2024-11-30 was $25.02B. Net income was $1.92B. Revenue was up 15.9% from 2023-11-30 to 2024-11-30. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
CCL currently screens at market cap $39.74B and trailing P/E 15.3. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the CCL and COLL stock pages for the full models.
Not investment advice.